Alzheimer's disease drug trial starts by region
3 regions, 2020 to 2025
78
Global, 2025
Alzheimer's disease drug trial starts by region: 3 regions, 2020 to 2025
Alzheimer's disease drug trial starts by region: 3 regions, 2020 to 2025. 3 regions on one axis: Global, United States, China. 18 observations from 2020 to 2025, ranging from 5 to 87. Latest values: Global 78 (2025); United States 34 (2025); China 16 (2025).
0
20
40
60
80
100
2020
2021
2022
2023
2024
2025
Global
United States
China
Alzheimer's disease drug trial starts by region: 3 regions, 2020 to 2025
Alzheimer's disease drug trial starts by region: 3 regions, 2020 to 2025. 3 regions on one axis: Global, United States, China. 18 observations from 2020 to 2025, ranging from 5 to 87. Latest values: Global 78 (2025); United States 34 (2025); China 16 (2025).
0
30
60
90
2020
2021
2022
2023
2024
2025
Global
United States
China
Alzheimer's disease drug trial starts by region: 3 regions, 2020 to 2025
Alzheimer's disease drug trial starts by region: 3 regions, 2020 to 2025. 3 regions on one axis: Global, United States, China. 18 observations from 2020 to 2025, ranging from 5 to 87. Latest values: Global 78 (2025); United States 34 (2025); China 16 (2025).
0
30
60
90
2020
2021
2022
2023
2024
2025
Global
United States
China
View the underlying data
Alzheimer's disease drug trial starts by region: 3 regions, 2020 to 2025
Region
Period
Type
Value
Global
2025
Actual
78
Global
2024
Actual
71
Global
2023
Actual
58
Global
2022
Actual
81
Global
2021
Actual
87
Global
2020
Actual
66
United States
2025
Actual
34
United States
2024
Actual
38
United States
2023
Actual
30
United States
2022
Actual
50
United States
2021
Actual
56
United States
2020
Actual
37
China
2025
Actual
16
China
2024
Actual
14
China
2023
Actual
5
China
2022
Actual
11
China
2021
Actual
12
China
2020
Actual
6
Chart:
StatOrigin
· Source: ClinicalTrials.gov ·
statorigin.org
CC BY 4.0